ARTICLE | Company News
Inhibitex infectious news
July 3, 2006 7:00 AM UTC
INHX said it now plans to in-license products or seek M&A opportunities instead of developing antibodies based on its microbial surface components recognizing adhesive matrix molecules (MSCRAMM) techn...